Can Water Fasting Cure Fatty Liver? Evidence, Risks & NHS Advice

Can water fasting cure fatty liver disease? It is a question increasingly asked by people diagnosed with non-alcoholic fatty liver disease (NAFLD) — a condition affecting an estimated one in three adults in the UK. With growing interest in fasting as a health intervention, it is important to examine what the evidence actually shows, what risks prolonged water fasting carries, and what NHS-recommended approaches genuinely work. This article explores the science behind water fasting and fatty liver, outlines the risks, and explains the lifestyle changes most likely to make a meaningful, lasting difference to your liver health.

What Is Fatty Liver Disease and How Does It Develop?

Fatty liver disease (NAFLD) occurs when excess fat accumulates in liver cells, driven by insulin resistance, obesity, type 2 diabetes, and a diet high in refined carbohydrates and sugar. It affects around one in three UK adults and is often silent until detected incidentally.

Fatty liver disease, known medically as hepatic steatosis, occurs when excess fat accumulates within liver cells. In the UK, the most common form is non-alcoholic fatty liver disease (NAFLD) — a term still widely used in UK clinical practice, though international guidelines are increasingly adopting the term metabolic dysfunction-associated steatotic liver disease (MASLD) to reflect its metabolic origins.^[2][7] NAFLD affects an estimated one in three adults in the UK to some degree (NHS, NAFLD patient information).^[1][3] A smaller proportion develop the more serious form, non-alcoholic steatohepatitis (NASH), where fat accumulation is accompanied by inflammation and, over time, potential scarring (fibrosis) or cirrhosis.

The condition develops primarily through metabolic dysfunction. Key contributing factors include:

• Obesity and excess visceral (abdominal) fat

• Type 2 diabetes and insulin resistance

• High triglyceride or cholesterol levels

• A diet high in refined carbohydrates, sugar, and saturated fat

• Physical inactivity

When the liver receives more fatty acids than it can process — either from dietary fat, de novo lipogenesis (conversion of excess carbohydrates into fat), or impaired fat oxidation — triglycerides accumulate within hepatocytes. Insulin resistance plays a particularly central role, as it promotes both increased fat delivery to the liver and reduced fat clearance.

Importantly, NAFLD is often silent in its early stages, with many people unaware they have it until it is detected incidentally on an ultrasound or through abnormal liver function tests (LFTs). NICE guidance (NG49) does not recommend routine screening for NAFLD in the general population.^[4] Instead, assessment should be considered when NAFLD is suspected or when LFTs are unexpectedly abnormal. Where NAFLD is confirmed or strongly suspected, NICE recommends risk stratification using the FIB-4 score (with age-adjusted cut-offs) as a first-line non-invasive test, followed by the Enhanced Liver Fibrosis (ELF) test (NICE DG43) as second-line assessment to guide referral decisions.^[4][5]

Red-flag symptoms requiring prompt medical attention include: jaundice (yellowing of the skin or eyes), ascites (abdominal swelling due to fluid), vomiting blood or passing black tarry stools, persistent confusion or drowsiness, and severe abdominal pain. If you experience any of these symptoms, seek urgent medical care — contact your GP immediately or call 999 in an emergency.

What Is Water Fasting and How Does It Affect the Body?

Water fasting involves consuming only water for a set period, prompting the body to deplete glycogen stores, enter ketosis, and trigger autophagy. However, prolonged water-only fasting beyond 24 hours is unsafe without medical supervision and is not recommended for many groups.

Water fasting is a practice in which an individual consumes nothing except water for a defined period — typically ranging from 24 hours to several days. It differs from other dietary approaches such as intermittent fasting (e.g., the 16:8 method) or time-restricted eating, which allow some caloric intake within set windows. During a water fast, the body receives zero calories, prompting significant metabolic adaptations.

In the initial 12–24 hours, the body depletes its glycogen (stored glucose) reserves in the liver and muscles. Once glycogen stores are exhausted, the body shifts into a state of ketosis, breaking down stored fat into ketone bodies to fuel the brain and other organs.^[6] This metabolic switch also triggers a process called autophagy — a cellular 'self-cleaning' mechanism in which damaged or dysfunctional cell components are broken down and recycled. Some researchers have proposed that autophagy may have beneficial effects on liver cells affected by fat accumulation; however, it is important to note that the clinical relevance of autophagy to NAFLD in humans remains unproven and speculative at this stage.^[6]

Additionally, water fasting leads to:

• Reduced insulin levels, which may improve insulin sensitivity

• Decreased hepatic fat synthesis due to the absence of dietary carbohydrates and fats

• Weight loss, primarily from fat stores, though also from muscle mass and water

Whilst these physiological changes may sound promising in theory, it is important to distinguish between short-term metabolic shifts and sustained, clinically meaningful improvements in liver health. Prolonged water-only fasting — beyond 24 hours — is not recommended without direct medical supervision and is unsafe for many people. It should never be self-initiated by individuals with existing health conditions (see the risks section below).

Groups who should not undertake water fasting include: people who are pregnant or breastfeeding, children and adolescents, those who are underweight or have a history of an eating disorder, older adults with frailty, people with chronic kidney disease, and anyone taking insulin or sulfonylureas (such as gliclazide) for diabetes. If you are taking any regular medication, do not make significant dietary changes without first speaking to your GP or pharmacist, as dose adjustments may be required.

What Does the Evidence Say About Fasting and Fatty Liver?

No robust clinical evidence supports water fasting as a cure for NAFLD, and no major health authority — including NICE, the NHS, or EASL — recommends it. Liver improvements in fasting studies are largely attributable to calorie reduction and weight loss rather than fasting specifically.

The question of whether water fasting can cure fatty liver disease requires careful examination of the available evidence. At present, there is no robust clinical evidence that water fasting specifically cures NAFLD, and no major health authority — including NICE, the NHS, or the European Association for the Study of the Liver (EASL) — recommends water fasting as a treatment for the condition.

That said, some preliminary research suggests that fasting-related interventions may have a beneficial effect on liver fat. A number of small studies and systematic reviews have found that intermittent fasting and calorie restriction can reduce hepatic steatosis, improve liver enzyme levels (such as ALT and AST), and enhance insulin sensitivity. However, most of this research has significant limitations:

• Small sample sizes and short follow-up periods

• Lack of randomised controlled trials specifically examining water fasting

• Difficulty distinguishing the effects of fasting from those of overall calorie reduction and weight loss

Critically, the liver improvements observed in fasting studies are largely attributed to weight loss and reduced caloric intake rather than fasting itself. Gradual, sustained calorie reduction through a balanced diet achieves similar or superior results with considerably fewer risks. EASL's 2024 MASLD Clinical Practice Guidelines reinforce that lifestyle modification — centred on dietary improvement and physical activity — remains the cornerstone of management, with no recommendation for water fasting.

It would therefore be misleading to claim that water fasting 'cures' fatty liver. The evidence does not support this conclusion, and the term 'cure' is not clinically appropriate for a condition that is better described as reversible through sustained lifestyle change.

NHS-Recommended Treatments for Fatty Liver Disease

NHS and NICE management of NAFLD centres on gradual weight loss of 7–10%, a Mediterranean-style diet, and at least 150 minutes of weekly moderate exercise. No drug is currently MHRA-approved specifically for NAFLD in the UK.

The NHS and NICE do not currently recommend any specific medication for NAFLD in the general population, as no drug has yet received MHRA approval specifically for this indication in the UK.^[10][11] Management is firmly grounded in lifestyle modification, with the primary goal of achieving gradual, sustained weight loss and improving metabolic health.

NICE guidance (NG49) and supporting evidence outline the following key recommendations for managing NAFLD:

• Gradual weight loss of approximately 7–10% of body weight is associated with significant reductions in liver fat and inflammation (a target supported by EASL and AASLD evidence-based guidelines); losing at least 5% of body weight can reduce liver fat, whilst greater losses of around 10% or more may improve fibrosis

• A balanced, calorie-controlled diet — such as a Mediterranean-style diet — is recommended over extreme dietary approaches

• Regular physical activity: at least 150 minutes of moderate-intensity exercise per week, in line with UK Chief Medical Officers' physical activity guidelines^[18][19]

• Management of associated conditions, including type 2 diabetes, hypertension, and dyslipidaemia

• Alcohol: people with NAFLD are advised to keep within the UK Chief Medical Officers' low-risk drinking guideline of no more than 14 units per week, spread across three or more days.^[12][13] Those with advanced fibrosis or cirrhosis should abstain from alcohol entirely, as it can accelerate liver damage

Risk stratification and referral: Where NAFLD is confirmed or suspected, NICE recommends using the FIB-4 score (with age-adjusted cut-offs) as a first-line non-invasive assessment. Those with an indeterminate or high FIB-4 score should proceed to the ELF test (NICE DG43) as second-line assessment. Elastography (FibroScan) is typically arranged in specialist or secondary care settings. Patients with indeterminate or high-risk scores, or where there is clinical concern, should be referred to hepatology. Liver biopsy may be required to stage disease accurately in selected cases.

Cardiovascular risk and statins: People with NAFLD have an increased cardiovascular risk. Statins are safe to use in NAFLD and should not be withheld; they should be prescribed according to standard CVD risk guidance.^[15][16]

Regular monitoring through LFTs and, where appropriate, non-invasive fibrosis assessment is advised for those with risk factors for disease progression. Patients are encouraged to discuss their individual management plan with their GP, who can refer to specialist dietetic or hepatology services where appropriate. Self-directed extreme interventions such as prolonged water fasting fall outside these evidence-based recommendations.

Risks of Water Fasting for People With Liver Conditions

Water fasting carries significant risks including electrolyte imbalances, refeeding syndrome, hypoglycaemia, muscle wasting, and acute kidney injury — risks that are compounded in those with advanced liver disease, diabetes, or who take regular medication.

Whilst water fasting may appear to offer a rapid solution, it carries meaningful risks — particularly for individuals who already have liver disease or associated metabolic conditions. These risks are important to understand before considering any form of prolonged fasting.

Metabolic and nutritional risks include:

• Muscle wasting (sarcopenia): Prolonged fasting causes the body to break down muscle protein for energy, which can worsen metabolic health and reduce physical function

• Electrolyte imbalances: Sodium, potassium, magnesium, and phosphate levels can drop dangerously, leading to cardiac arrhythmias, muscle cramps, or neurological symptoms

• Refeeding syndrome: Resuming food after prolonged fasting can cause a dangerous shift in electrolytes — particularly phosphate — which can be life-threatening in severe cases. NICE guidance (CG32, Nutrition support in adults) identifies those at risk and sets out the need for supervised, gradual reintroduction of nutrition

• Hypoglycaemia: Particularly dangerous for individuals with diabetes or those taking glucose-lowering medicines such as insulin or sulfonylureas

• Dehydration and orthostatic hypotension: Dizziness and fainting on standing are common, increasing the risk of falls

• Raised uric acid levels: Fasting can precipitate gout flares in susceptible individuals

• Acute kidney injury: Particularly in those with pre-existing kidney disease or who become significantly dehydrated

For people with advanced NAFLD, cirrhosis, or impaired liver function, the risks are compounded. The liver plays a central role in gluconeogenesis (producing glucose during fasting), and a compromised liver may be unable to maintain blood glucose levels safely during extended fasting periods.

There is also a concern that rapid weight loss — which water fasting can induce — may paradoxically worsen liver inflammation in some individuals. Very rapid weight loss (more than approximately 1.5 kg per week) can increase the risk of gallstone formation and may temporarily elevate liver enzymes (NHS, Gallstones).

Medicine safety: If you take insulin, sulfonylureas, or other glucose-lowering medicines, do not fast without first speaking to your GP or diabetes team, as your doses may need to be adjusted. Diabetes UK provides specific guidance on fasting and diabetes safety. Do not stop or alter any prescribed medicine without medical advice.

Seek urgent medical attention (call 999 or go to A&E) if during or after fasting you experience: loss of consciousness or fainting, chest pain or palpitations, severe confusion or difficulty speaking, or inability to keep fluids down.

Anyone considering fasting with a known liver condition, diabetes, cardiovascular disease, chronic kidney disease, or who is taking regular medication should consult their GP before making any dietary changes. Prolonged water fasting should never be undertaken without medical supervision in these groups.

If you think you have experienced a side effect from a medicine — for example, following a dose adjustment related to weight loss or diabetes management — you can report it via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Lifestyle Changes That Can Help Improve Fatty Liver

NAFLD is reversible in its early stages through sustained lifestyle changes: a Mediterranean diet, reduced ultra-processed food intake, gradual calorie deficit, and regular physical activity can reduce liver fat and, in some cases, resolve the condition entirely.

The encouraging reality of NAFLD is that, in its early and moderate stages, it is a reversible condition. Sustained, evidence-based lifestyle changes have been shown to reduce liver fat, improve liver enzyme levels, and in some cases resolve the condition entirely — without the need for extreme interventions such as water fasting.

Dietary changes with the strongest evidence include:

• Adopting a Mediterranean diet — rich in vegetables, legumes, wholegrains, oily fish, olive oil, and nuts — which has been shown in studies to reduce hepatic fat, including independently of weight loss (EASL 2024 MASLD guidelines; NHS NAFLD patient information)^[7][8]

• Reducing intake of ultra-processed foods, added sugars, and sugar-sweetened beverages, particularly those containing fructose, which is directly metabolised by the liver into fat

• Moderating portion sizes to achieve a gradual calorie deficit of around 500–600 kcal per day, aiming for weight loss of 0.5–1 kg per week — in line with NHS and NICE obesity management guidance (NICE CG189 and successor guidance)

• Alcohol: keep within the UK Chief Medical Officers' low-risk guideline of no more than 14 units per week; those with advanced fibrosis or cirrhosis should abstain entirely

Physical activity is equally important. Both aerobic exercise (such as brisk walking, cycling, or swimming) and resistance training have been shown to reduce liver fat, even in the absence of significant weight loss.^[20][7] Exercise improves insulin sensitivity and promotes fat oxidation within the liver. Adults should aim for at least 150 minutes of moderate-intensity activity per week, in line with UK Chief Medical Officers' physical activity guidelines.^[18][19]

Graded benefits of weight loss: Losing as little as 5% of body weight can meaningfully reduce liver fat. Losses of around 7–10% are associated with improvements in liver inflammation (NASH), and losses of 10% or more may improve liver fibrosis in some individuals (EASL 2024 MASLD guidelines).

Other supportive measures include:

• Improving sleep quality, as poor sleep and obstructive sleep apnoea are associated with worsened NAFLD^[21]

• Managing stress, which can influence cortisol levels and metabolic health

• Regular GP reviews to monitor liver function, blood glucose, lipids, and blood pressure

These changes, when maintained consistently over months and years, offer the most reliable and safest path to improving fatty liver disease. If you are unsure where to start, your GP can refer you to a dietitian or a structured weight management programme available through the NHS.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD).
2. Understanding the evolving nomenclature of steatotic liver disease.
3. Global Epidemiological Patterns and Disease Burden of MASLD, MetALD, and ALD.
4. Non-alcoholic fatty liver disease (NAFLD): assessment and management — NG49.
5. Using the ELF test, FIB-4 and NAFLD fibrosis score to assess liver fibrosis.
6. Intermittent metabolic switching, neuroplasticity and brain health.
7. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
8. EASL-EASD-EASO Clinical Practice Guidelines on the management of MASLD: Executive Summary.
9. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
10. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
11. GID-TA11477 Draft Scope (post-referral).
12. Alcohol consumption: advice on low risk drinking — UK Chief Medical Officers.
13. Alcohol units.
14. Nutrition support for adults (CG32) — recommendations (refeeding syndrome).
15. Safety and efficacy of dyslipidaemia treatment in NAFLD patients: a meta-analysis of randomised controlled trials.
16. Impact of statins in the liver: A bane or a boon?.
17. Gallstones.
18. UK Chief Medical Officers' physical activity guidelines.
19. Physical activity guidelines for adults aged 19 to 64.
20. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
21. Sleep Disorders and Nonalcoholic Fatty Liver Disease: Evidence From Meta-Analysis and Mendelian Randomization.

Frequently Asked Questions